Literature DB >> 27182681

The Discrepancy between Performance-Based Measures and Questionnaires when Assessing Clinical Outcomes and Quality of Life in Pediatric Patients with Neurological Disorders.

V Coutinho1,2,3,4, H Câmara-Costa3, I Kemlin1,2, T Billette de Villemeur1,5,6, D Rodriguez1,2,5,6, G Dellatolas3.   

Abstract

In clinical outcome assessment, the relation between performance-based measures and questionnaire ratings of the same domain is weak, but correlations between questionnaires proposed for the evaluation of different domains are strong. The present study aims to illustrate these phenomena in a group of patients with neurofibromatosis type 1 (NF1) and to propose an explanatory hypothesis. A single neuropsychologist interviewed the parents about the child's situation and current difficulties and then assessed this parental view as overall positive or overall negative. The same assessor then administered the Wechsler Intelligence Scales and neuropsychological tests to 78 children and adolescents with NF1 (5-18 years). Parents then completed the Child Behavioral Checklist (CBCL), the Conners' Parent Rating Scale, the Behavior Rating Inventory of Executive Function (BRIEF), as well as questionnaires assessing quality of life, impact of the medical disorder, and their own difficulties. All questionnaires were inter-correlated (r = 0.29 - 0.84) and associated with the overall positive or negative parental view of the child's progress (effect size = 0.41-1.46). Conversely, questionnaires were weakly or not significantly related to intelligence, cognitive measures, or clinical severity. In conclusion, the parental view of the child's progress was related to the answers to questionnaires assessing quality of life or strengths and difficulties of patients with a neurological disorder. This factor should be assessed independently and taken into account when assessing clinical outcome.

Entities:  

Keywords:  Assessment; neurofibromatosis type 1; neuropsychological tests; outcome; parental reports

Mesh:

Year:  2016        PMID: 27182681     DOI: 10.1080/21622965.2016.1146141

Source DB:  PubMed          Journal:  Appl Neuropsychol Child        ISSN: 2162-2965            Impact factor:   1.493


  6 in total

1.  Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).

Authors:  Lori Wiener; Haven Battles; Sima Zadeh Bedoya; Andrea Baldwin; Brigitte C Widemann; Maryland Pao
Journal:  J Genet Couns       Date:  2017-07-23       Impact factor: 2.537

2.  Self- and parent-reported Quality of Life 7 years after severe childhood traumatic brain injury in the Traumatisme Grave de l'Enfant cohort: associations with objective and subjective factors and outcomes.

Authors:  Hugo Câmara-Costa; Marion Opatowski; Leila Francillette; Hanna Toure; Dominique Brugel; Anne Laurent-Vannier; Philippe Meyer; Laurence Watier; Georges Dellatolas; Mathilde Chevignard
Journal:  Qual Life Res       Date:  2019-09-23       Impact factor: 4.147

3.  Clinical Management of Children and Adolescents with Neurofibromatosis Type 1 Like Phenotypes and Complex Behavioural Manifestations: A Multidisciplinary and Dimensional Approach.

Authors:  Ana Moscoso; Aurélie Julien; Antoine Tanet; Angèle Consoli; Martine Pagnard; France Trevisan; Isabelle Kemlin; Diana Rodriguez; David Cohen
Journal:  Case Rep Psychiatry       Date:  2019-12-31

Review 4.  Core deficits and quality of survival after childhood medulloblastoma: a review.

Authors:  Mathilde Chevignard; Hugo Câmara-Costa; François Doz; Georges Dellatolas
Journal:  Neurooncol Pract       Date:  2016-08-26

5.  Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

Authors:  Hugo Câmara-Costa; Kim S Bull; Colin Kennedy; Andreas Wiener; Gabriele Calaminus; Anika Resch; Virginie Kieffer; Clémence Lalande; Geraldina Poggi; Katja von Hoff; Jacques Grill; François Doz; Stefan Rutkowski; Maura Massimino; Rolf-Dieter Kortmann; Birgitta Lannering; Georges Dellatolas; Mathilde Chevignard
Journal:  Neurooncol Pract       Date:  2017-02-10

6.  Predictors of cognitive function in pediatric brain tumor patients: Pre-surgery through 24-month follow-up.

Authors:  Claire E Fraley; Jennifer C Thigpen; Matthew M Pearson; John F Kuttesch; Leandra Desjardins; Kristen R Hoskinson; Abraham Alvarado-Gonzalez; Adam J Esbenshade; Devang Pastakia; Debra L Friedman; John C Wellons; Colleen M McNally; Rachel E Siciliano; Bruce E Compas
Journal:  Appl Neuropsychol Child       Date:  2019-12-30       Impact factor: 1.613

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.